Search
for
Sort by
Research 811–840 of 1000+
- Drug Information Analysis Service
- Dermatologic therapy: December 1987 to December 1988
- Cytostatics and immunosuppressive drugs
- Does smoking affect your skin?
- Pharmacology of Natural Volatiles and Essential Oils in Food, Therapy, and Disease Prophylaxis
- Kombinationsbehandlung des BPS mit Tamsulosin und Finasterid
- Alopecia Universalis Successfully Treated With Adalimumab
- The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial
- Spironolacton in dermatologischen Behandlungen
- Tissue distribution and hypotensive effects of minoxidil in normotensive rats.
- In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole
- Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency Due to an Interaction Between Fluticasone and Ritonavir
- Pharmacological inhibition of 5α-reductase in androgenetic alopecia: a comparative narrative review of finasteride and dutasteride, with attention to responder heterogeneity and female pattern hair loss
- Pharmacological inhibition of 5α-reductase in androgenetic alopecia: a comparative narrative review of finasteride and dutasteride, with attention to responder heterogeneity and female pattern hair loss
- Managing Skin Diseases that Flare During Pregnancy and in the Postpartum period: Part 2- Management & Safety Considerations
- Drug Repurposing: Accelerating New Therapeutic Discoveries from Old Molecules (1990 – 2025)
- Drug Repurposing: Accelerating New Therapeutic Discoveries from Old Molecules (1990 – 2025)
- Evaluation of the efficacy of topical metformin 10% and 20% versus topical potent steroid in the treatment of patients with alopecia areata
- Review of Baricitinib in the Treatment of Alopecia Areata.
- Development of Microemulsions<i> </i>Containing<i> Carthamus tinctorius</i> Extract for 5α-Reductase Inhibition
- Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies
- Approaches for estimating the clinical starting dose of new dosage forms: An example of a long-acting injectable formulation of finasteride
- Topical finasteride dose evaluation for treatment of androgenetic alopecia using computer simulations
- Successful treatment with hydroxychloroquine for systemic lupus erythematosus with cutaneous involvement accompanied by a xanthomatous reaction
- Pharmaceutical care in transplantation: current challenges and future opportunities
- Investigations of 13 Genes in Non-Cicatricial Alopecia
- Beliefs and counseling practices among dermatologists regarding sexual and other adverse effects of finasteride
- General adverse response to cyclophosphamide in Chinese patients with systemic autoimmune diseases in recent decade — a single-center retrospective study
- Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality
- In vitro biotransformation of finasteride in rat hepatic microsomes. Isolation and characterization of metabolites.